ArticleTargeted oncology2021

Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience.

Margherita Rimini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.